Hansen, Emma B.
Karlsson, Questa
Merson, Susan
Wakerell, Sarah
Rageevakumar, Reshma
Jensen, Jørgen B.
Borre, Michael
Kote-Jarai, Zsofia
Eeles, Rosalind A. http://orcid.org/0000-0002-3698-6241
Sørensen, Karina D. http://orcid.org/0000-0002-4902-5490
Funding for this research was provided by:
Novo Nordisk Fonden (NNF20OC0059410, NNF20OC0059410)
Kræftens Bekæmpelse (R99-A6338-14-S25, R281-A16122)
Harboefonden (21112)
The Graduate School of Health, Aarhus University
Christian og Ottilia Brorsons Travel Grant (#12038-1)
Rosetrees Trust
Cancer Research UK
Prostate Cancer UK
Article History
Received: 9 August 2023
Accepted: 30 October 2023
First Online: 6 November 2023
Competing interests
: K.D.S has received honoraria (outside of this submitted study) from Sanofi, AstraZeneca and MSD. R.E. has received honoraria (outside of this submitted study) from GU-ASCO, The Royal Marsden NHS Foundation Trust, University of Chicago, ESMO, and AstraZeneca UK Limited. R.E. undertakes private practice in London UK. All remaining authors declare no competing interests.